繁體中文 简体中文

研究發表

106年度研究論文

篇序

作者
(順位)

論文題目 發表雜誌名稱
(
含年月/卷期/頁次)
屬性
(SCI、SSCI、IEEE)
1 湯宏仁(1) Nontyphoidal Salmonella urinary tract infection among elderly patients J Microbiol Immunol Infect. 2016 Feb;49(1):157-8  SCI
2 湯宏仁(1) Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity. Front Microbiol. 2017 May 18;8:884  SCI
3 湯宏仁(C) Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate Int J Antimicrob Agents. 2017 Apr;49(4):517-518  SCI
4 湯宏仁(C) Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA Sci Rep. 2017 Jan 31;7:41758.  SCI
5 湯宏仁(C) Clostridium tetani bacteremia in a patient with cirrhosis following transarterial chemoembolization treatment for hepatocellular carcinoma. J Microbiol Immunol Infect. 2018 Feb;51(1):155-156.  SCI
6 湯宏仁(C) The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms. J Microbiol Immunol Infect. 2017 Oct 6. pii: S1684-1182(17)30226-8.  SCI
7 湯宏仁(2) Increasing resistance to fluoroquinolones among Haemophilus species in Southern Taiwan. J Microbiol Immunol Infect. 2017 Apr;50(2):258-260  SCI
8 湯宏仁(3) Desiccation and ethanol resistances of multidrug resistant Acinetobacter baumannii embedded in biofilm: The favorable antiseptic efficacy of combination chlorhexidine gluconate and ethanol. J Microbiol Immunol Infect. 2017 Jun 28. pii: S1684-1182(17)30083-X.  SCI
9 湯宏仁(4) Impacts of Hypervirulence Determinants on Clinical Features and Outcomes of Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Microb Drug Resist. 2017 Apr;23(3):376-383  SCI
10 湯宏仁(4) Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia Crit Care. 2017 May 26;21(1):119  SCI
11 湯宏仁(5) Propensity-matched analysis of the impact of extended-spectrum β-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia. J Microbiol Immunol Infect. 2017 Jun 29. pii: S1684-1182(17)30098-1.  SCI
12 湯宏仁(5) Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance J Microbiol Immunol Infect. 2017 Dec;50(6):931-939.  SCI
13 湯宏仁(6) Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremia Int J Antimicrob Agents. 2017 Sep;50(3):371-376  SCI
14 湯宏仁(6) Klebsiella pneumoniae Isolates from Meningitis: Epidemiology, Virulence and Antibiotic Resistance. Sci Rep. 2017 Jul 26;7(1):6634.  SCI
15 湯宏仁(7) Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014. J Microbiol Immunol Infect. 2017 Aug 26. pii: S1684-1182(17)30188-3.  SCI
16 湯宏仁(7) Taiwan HIV Study Group. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.  PLoS One. 2017 Oct 16;12(10):e0186338  SCI
17 湯宏仁(7) Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-onset Bacteremia in Comparison with Third-generation Cephalosporin Therapy. Antimicrob Agents Chemother. 2017 Jan 24;61(2)  SCI
18 湯宏仁(8) Taiwan HIV Study Group. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up PLoS One. 2017 Jun 30;12(6):e0179870  SCI
19 湯宏仁(13) Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan. PLoS One. 2017 Feb 21;12(2):e0171596  SCI